LifeStance Health Group (NASDAQ:LFST) Hits New 52-Week Low - Time to Sell?

LifeStance Health Group, Inc. (NASDAQ:LFST - Get Free Report)'s share price reached a new 52-week low during trading on Monday . The stock traded as low as $4.42 and last traded at $4.49, with a volume of 145403 shares trading hands. The stock had previously closed at $4.51.

Analyst Upgrades and Downgrades

LFST has been the topic of several research reports. UBS Group raised LifeStance Health Group from a "neutral" rating to a "buy" rating and set a $8.50 target price on the stock in a research report on Tuesday, May 27th. KeyCorp began coverage on LifeStance Health Group in a report on Tuesday, April 8th. They set an "overweight" rating and a $9.00 target price for the company. Finally, Canaccord Genuity Group began coverage on LifeStance Health Group in a report on Thursday, April 3rd. They set a "buy" rating and a $8.00 target price for the company. One analyst has rated the stock with a sell rating, four have given a buy rating and one has given a strong buy rating to the company. According to MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average target price of $8.50.

LifeStance Health Group Stock Up 0.6%

The firm has a market cap of $1.72 billion, a price-to-earnings ratio of -44.15 and a beta of 1.16. The company has a debt-to-equity ratio of 0.19, a current ratio of 1.47 and a quick ratio of 1.47. The stock has a 50-day moving average of $5.35 and a 200-day moving average of $6.62.

Insider Transactions at LifeStance Health Group

In related news, insider Ujjwal Ramtekkar sold 16,000 shares of the stock in a transaction that occurred on Thursday, June 5th. The stock was sold at an average price of $5.94, for a total transaction of $95,040.00. Following the sale, the insider owned 113,435 shares of the company's stock, valued at $673,803.90. This represents a 12.36% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. 3.20% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On LifeStance Health Group

A number of large investors have recently added to or reduced their stakes in the stock. Choreo LLC lifted its stake in LifeStance Health Group by 6.4% during the first quarter. Choreo LLC now owns 27,420 shares of the company's stock worth $183,000 after purchasing an additional 1,661 shares during the last quarter. LPL Financial LLC lifted its stake in LifeStance Health Group by 6.0% during the fourth quarter. LPL Financial LLC now owns 37,584 shares of the company's stock worth $277,000 after purchasing an additional 2,127 shares during the last quarter. Invesco Ltd. lifted its stake in LifeStance Health Group by 1.4% during the first quarter. Invesco Ltd. now owns 164,384 shares of the company's stock worth $1,095,000 after purchasing an additional 2,238 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its stake in LifeStance Health Group by 2.4% during the fourth quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 138,781 shares of the company's stock worth $1,023,000 after purchasing an additional 3,305 shares during the last quarter. Finally, DekaBank Deutsche Girozentrale bought a new stake in LifeStance Health Group during the first quarter worth $31,000. Institutional investors and hedge funds own 85.50% of the company's stock.

LifeStance Health Group Company Profile

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.